Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Abern

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Urologic Oncology|June 2, 2015
Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancerJoseph J Fantony, Michael R Abern, Ajay Gopalakrishna, et al.
Minerva Urology and Nephrology|March 26, 2021
Single-Port robot assisted partial nephrectomy: initial experience and technique with the da Vinci Single-Port platform (IDEAL Phase 1)Simone Francavilla, Michael R Abern, Ryan W Dobbs, et al.
Annals of Surgical Oncology|October 26, 2020
Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the USHari T Vigneswaran, Logan S Schwarzman, Ikenna C Madueke, et al.
The Canadian Journal of Urology|June 17, 2020
Single port robotic radical prostatectomy with the da Vinci SP platform: a step by step approachRabun Jones, Ryan W Dobbs, Whitney R Halgrimson, et al.
European Urology Oncology|July 25, 2022
Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion - Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target AnalysisSrinath Kotamarti, Rajan T Gupta, Bangchen Wang, et al.
The Prostate|September 22, 2012
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH databaseMichael R Abern, William J Aronson, Martha K Terris, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 19, 2016
Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathologyMatvey Tsivian, Rajan T Gupta, Efrat Tsivian, et al.
Cancer|March 21, 2014
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancerMichael R Abern, Martha K Terris, William J Aronson, et al.
Urologic Oncology|April 4, 2026
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World ExperienceAlireza Ghoreifi, Christopher J Hoimes, Sundhar Ramalingam, et al.
The Journal of Urology|April 17, 2014
Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysisHsin-Hsiao S Wang, Michael R Abern, Nicholas G Cost, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Urologic Oncology|June 2, 2015
Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancerJoseph J Fantony, Michael R Abern, Ajay Gopalakrishna, et al.
Minerva Urology and Nephrology|March 26, 2021
Single-Port robot assisted partial nephrectomy: initial experience and technique with the da Vinci Single-Port platform (IDEAL Phase 1)Simone Francavilla, Michael R Abern, Ryan W Dobbs, et al.
Annals of Surgical Oncology|October 26, 2020
Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the USHari T Vigneswaran, Logan S Schwarzman, Ikenna C Madueke, et al.
The Canadian Journal of Urology|June 17, 2020
Single port robotic radical prostatectomy with the da Vinci SP platform: a step by step approachRabun Jones, Ryan W Dobbs, Whitney R Halgrimson, et al.
European Urology Oncology|July 25, 2022
Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion - Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target AnalysisSrinath Kotamarti, Rajan T Gupta, Bangchen Wang, et al.
The Prostate|September 22, 2012
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH databaseMichael R Abern, William J Aronson, Martha K Terris, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 19, 2016
Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathologyMatvey Tsivian, Rajan T Gupta, Efrat Tsivian, et al.
Cancer|March 21, 2014
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancerMichael R Abern, Martha K Terris, William J Aronson, et al.
Urologic Oncology|April 4, 2026
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World ExperienceAlireza Ghoreifi, Christopher J Hoimes, Sundhar Ramalingam, et al.
The Journal of Urology|April 17, 2014
Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysisHsin-Hsiao S Wang, Michael R Abern, Nicholas G Cost, et al.
Pageof 9